| scholarly article | Q13442814 |
| P2093 | author name string | Lin Zhao | |
| Yi Zhang | |||
| Lijun Wang | |||
| Jianming Wang | |||
| Xiting Yang | |||
| Aiyi Zhou | |||
| P2860 | cites work | Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels | Q24299513 |
| Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1 | Q24304277 | ||
| Ranibizumab and bevacizumab for neovascular age-related macular degeneration | Q24616209 | ||
| The basics of epithelial-mesenchymal transition | Q24652992 | ||
| Molecular mechanisms of epithelial-mesenchymal transition | Q27013743 | ||
| Sustained inflammation after pericyte depletion induces irreversible blood-retina barrier breakdown | Q28817495 | ||
| Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization | Q31147566 | ||
| The development of an experimental model of subretinal neovascularization in disciform macular degeneration | Q32116650 | ||
| Inhibitory effect of nuclear factor-κB decoy oligodeoxynucleotide on liver fibrosis through regulation of the epithelial-mesenchymal transition | Q34063617 | ||
| The discovery of placenta growth factor and its biological activity. | Q34245619 | ||
| A systems view of epithelial-mesenchymal transition signaling states | Q34579646 | ||
| Retracted: Vascular Endothelial Growth Factor Receptor-1 Activation Promotes Migration and Invasion of Breast Cancer Cells through Epithelial-Mesenchymal Transition | Q34775622 | ||
| VEGF receptor blockade markedly reduces retinal microglia/macrophage infiltration into laser-induced CNV. | Q34972337 | ||
| Paediatric cholestatic liver disease: Diagnosis, assessment of disease progression and mechanisms of fibrogenesis. | Q34992341 | ||
| Placenta growth factor promotes migration through regulating epithelial-mesenchymal transition-related protein expression in cervical cancer | Q35038699 | ||
| Risk of scar in the comparison of age-related macular degeneration treatments trials | Q35062089 | ||
| Choroidal neovascularization: a wound healing perspective. | Q35634483 | ||
| Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases | Q35649473 | ||
| PlGF knockout delays brain vessel growth and maturation upon systemic hypoxic challenge | Q35866840 | ||
| The biology of vascular endothelial growth factors. | Q36017169 | ||
| The retinal pigment epithelium in visual function | Q36178984 | ||
| Promising new treatments for neovascular age-related macular degeneration | Q36512564 | ||
| Transplantation of the RPE in AMD. | Q36833137 | ||
| Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy? | Q37849269 | ||
| Predictors of 1-year visual outcome in neovascular age-related macular degeneration following intravitreal ranibizumab treatment | Q37946988 | ||
| Angiogenesis: a target in solid tumors, also in leukemia? | Q37967243 | ||
| Biomechanics of TGFβ-induced epithelial-mesenchymal transition: implications for fibrosis and cancer | Q38237390 | ||
| TNF-α-induced NF-κB activation promotes myofibroblast differentiation of LR-MSCs and exacerbates bleomycin-induced pulmonary fibrosis. | Q38668289 | ||
| Differential hypoxic response of human choroidal and retinal endothelial cells proposes tissue heterogeneity of ocular angiogenesis | Q38766945 | ||
| Osmotic induction of placental growth factor in retinal pigment epithelial cells in vitro: contribution of NFAT5 activity | Q39732887 | ||
| Characteristics of Patients Losing Vision after 2 Years of Monthly Dosing in the Phase III Ranibizumab Clinical Trials | Q39830867 | ||
| Hepatitis B virus X protein promotes renal epithelial-mesenchymal transition in human renal proximal tubule epithelial cells through the activation of NF-κB. | Q40695291 | ||
| miR-200b is involved in intestinal fibrosis of Crohn's disease | Q41848371 | ||
| Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab | Q42139247 | ||
| Kaempferol inhibited VEGF and PGF expression and in vitro angiogenesis of HRECs under diabetic-like environment | Q42275049 | ||
| Oxidative stress, hypoxia, and autophagy in the neovascular processes of age-related macular degeneration. | Q42413400 | ||
| Sorafenib protects human optic nerve head astrocytes from light-induced overexpression of vascular endothelial growth factor, platelet-derived growth factor, and placenta growth factor | Q43157760 | ||
| Epithelial-mesenchymal transition and proliferation of retinal pigment epithelial cells initiated upon loss of cell-cell contact | Q43204589 | ||
| Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. | Q43592482 | ||
| KH902 suppresses high glucose-induced migration and sprouting of human retinal endothelial cells by blocking VEGF and PIGF. | Q46306730 | ||
| Human retinal epithelium produces and responds to placenta growth factor | Q46845630 | ||
| Identification of proteins associated with clinical and pathological features of proliferative diabetic retinopathy in vitreous and fibrovascular membranes | Q47130506 | ||
| Inhibition of Placenta Growth Factor Reduces Subretinal Mononuclear Phagocyte Accumulation in Choroidal Neovascularization | Q47694964 | ||
| High Uric Acid-Induced Epithelial-Mesenchymal Transition of Renal Tubular Epithelial Cells via the TLR4/NF-kB Signaling Pathway. | Q47826501 | ||
| Gypsophila elegans isoorientin-2″-O-α-l-arabinopyranosyl ameliorates porcine serum-induced immune liver fibrosis by inhibiting NF-κB signaling pathway and suppressing HSC activation | Q50136523 | ||
| Placenta growth factor contributes to cell apoptosis and epithelial-to-mesenchymal transition in the hyperoxia-induced acute lung injury. | Q53094662 | ||
| Placental Growth Factor Triggers Epithelial-to-Mesenchymal Transition-like Changes in Rat Type II Alveolar Epithelial Cells: Activation of Nuclear Factor κB Signalling Pathway. | Q53611300 | ||
| PlGF gene knockdown in human retinal pigment epithelial cells. | Q54400583 | ||
| Further Pharmacological and Genetic Evidence for the Efficacy of PlGF Inhibition in Cancer and Eye Disease | Q57983635 | ||
| Transdifferentiation of retinal pigment epithelial cells from epithelial to mesenchymal phenotype | Q71671878 | ||
| Efficacy and safety of monthly versus quarterly ranibizumab treatment in neovascular age-related macular degeneration: the EXCITE study | Q82826313 | ||
| Placental growth factor expression is reversed by antivascular endothelial growth factor therapy under hypoxic conditions | Q87580285 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P304 | page(s) | 340-352 | |
| P577 | publication date | 2018-04-26 | |
| P1433 | published in | Molecular Vision | Q6895981 |
| P1476 | title | Placental growth factor promotes epithelial-mesenchymal transition-like changes in ARPE-19 cells under hypoxia. | |
| P478 | volume | 24 |
Search more.